Canonical: https://ownershiptrace.com/13f/companies/4166

# Who owns Eton Pharmaceuticals, Inc. (AVEO)? Elite investor 13F holders

5 tracked elite investors reported holding Eton Pharmaceuticals, Inc as of 2026-06-30, including Cannell Capital, D.E. Shaw, Renaissance Technologies LLC, Polen Capital Management, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Cannell Capital](https://ownershiptrace.com/13f/investors/132) | ETON PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-18 00:00:00 | 6181041.00 USD | 170747.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1058854/0001420506-26-001852-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | ETON PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 6821962.00 USD | 188452.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | ETON PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 1893260.00 USD | 52300.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [Polen Capital Management](https://ownershiptrace.com/13f/investors/61) | ETON PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-04 00:00:00 | 1642720.00 USD | 45379.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1034524/0001172661-26-003035-index.html) |
| [Gotham Asset Management](https://ownershiptrace.com/13f/investors/94672) | ETON PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 578548.00 USD | 15982.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1510387/0001398344-26-014644-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)